IE40794B1 - Influenza vaccines - Google Patents

Influenza vaccines

Info

Publication number
IE40794B1
IE40794B1 IE59/75A IE5975A IE40794B1 IE 40794 B1 IE40794 B1 IE 40794B1 IE 59/75 A IE59/75 A IE 59/75A IE 5975 A IE5975 A IE 5975A IE 40794 B1 IE40794 B1 IE 40794B1
Authority
IE
Ireland
Prior art keywords
influenza
components
virus
type
cationic detergent
Prior art date
Application number
IE59/75A
Other languages
English (en)
Other versions
IE40794L (en
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of IE40794L publication Critical patent/IE40794L/xx
Publication of IE40794B1 publication Critical patent/IE40794B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
  • Enzymes And Modification Thereof (AREA)
IE59/75A 1974-01-14 1975-01-13 Influenza vaccines IE40794B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH44774A CH589453A5 (enExample) 1974-01-14 1974-01-14

Publications (2)

Publication Number Publication Date
IE40794L IE40794L (en) 1975-07-14
IE40794B1 true IE40794B1 (en) 1979-08-15

Family

ID=4187233

Family Applications (1)

Application Number Title Priority Date Filing Date
IE59/75A IE40794B1 (en) 1974-01-14 1975-01-13 Influenza vaccines

Country Status (27)

Country Link
JP (2) JPS58407B2 (enExample)
AT (1) AT345449B (enExample)
AU (1) AU500250B2 (enExample)
BE (1) BE824372A (enExample)
CA (1) CA1049406A (enExample)
CH (1) CH589453A5 (enExample)
CS (1) CS191254B2 (enExample)
DD (1) DD116239A5 (enExample)
DE (1) DE2500785B2 (enExample)
DK (1) DK140003B (enExample)
ES (1) ES433759A1 (enExample)
FI (1) FI54053C (enExample)
FR (1) FR2257305B1 (enExample)
GB (1) GB1498261A (enExample)
HK (1) HK56380A (enExample)
HU (1) HU173920B (enExample)
IE (1) IE40794B1 (enExample)
IL (1) IL46426A (enExample)
MY (1) MY8100204A (enExample)
NL (1) NL166622C (enExample)
NO (1) NO143128C (enExample)
PH (1) PH14458A (enExample)
PL (1) PL93689B1 (enExample)
SE (1) SE427238B (enExample)
SU (1) SU616997A3 (enExample)
YU (1) YU41289B (enExample)
ZA (1) ZA75259B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2829089A1 (de) * 1977-07-13 1979-02-01 Sandoz Ag Subunit-vakzine
JPH0688911B2 (ja) * 1985-06-06 1994-11-09 国立予防衛生研究所長 インフルエンザワクチン及びその製造方法
TW570803B (en) * 1997-04-09 2004-01-11 Duphar Int Res Influenza vaccine
EP0919243A1 (en) 1997-11-25 1999-06-02 Duphar International Research B.V Vaccine containing B subunits of heat-labile enterotoxin (LTB) of Escherichia coli as an adjuvant
DE19938767C2 (de) * 1999-08-16 2002-10-24 Tad Pharma Gmbh Spaltimpfstoffe
ES2359214T5 (es) * 2005-11-01 2014-10-08 Novartis Vaccines And Diagnostics Gmbh Vacunas virales derivadas de células con niveles reducidos de ADN celular residual por tratamiento con beta-propiolactona
US8497112B2 (en) * 2007-08-28 2013-07-30 Baxter International Inc. Method for producing viral vaccines
US20160287693A1 (en) 2013-11-15 2016-10-06 Novartis Ag Removal of residual cell culture impurities

Also Published As

Publication number Publication date
IL46426A (en) 1978-01-31
DE2500785C3 (enExample) 1980-09-11
DD116239A5 (enExample) 1975-11-12
JPS50100224A (enExample) 1975-08-08
GB1498261A (en) 1978-01-18
NO143128C (no) 1980-12-29
ZA75259B (en) 1976-08-25
DK140003B (da) 1979-06-05
MY8100204A (en) 1981-12-31
BE824372A (fr) 1975-07-14
JPS6035326B2 (ja) 1985-08-14
NL166622B (nl) 1981-04-15
FI750014A7 (enExample) 1975-07-15
CS191254B2 (en) 1979-06-29
ES433759A1 (es) 1977-02-16
FR2257305B1 (enExample) 1982-03-19
YU41289B (en) 1987-02-28
DK1475A (enExample) 1975-09-01
IE40794L (en) 1975-07-14
ATA21475A (de) 1978-01-15
JPS58407B2 (ja) 1983-01-06
DE2500785B2 (de) 1980-01-03
YU5875A (en) 1984-04-30
DE2500785A1 (de) 1975-07-31
FI54053C (fi) 1978-10-10
SE7500130L (enExample) 1975-07-15
NO750031L (enExample) 1975-08-11
CA1049406A (en) 1979-02-27
NL166622C (nl) 1981-09-15
NL7500301A (nl) 1975-07-16
HU173920B (hu) 1979-09-28
AU7730575A (en) 1976-07-15
HK56380A (en) 1980-10-16
FI54053B (fi) 1978-06-30
DK140003C (enExample) 1979-10-29
JPS56127319A (en) 1981-10-06
SU616997A3 (ru) 1978-07-25
AU500250B2 (en) 1979-05-17
AT345449B (de) 1978-09-11
SE427238B (sv) 1983-03-21
FR2257305A1 (enExample) 1975-08-08
IL46426A0 (en) 1975-04-25
NO143128B (no) 1980-09-15
PH14458A (en) 1981-07-29
PL93689B1 (enExample) 1977-06-30
CH589453A5 (enExample) 1977-07-15

Similar Documents

Publication Publication Date Title
AU2684792A (en) Porcine reproductive respiratory syndrome vaccine and diagnostic
IE40794B1 (en) Influenza vaccines
Lahelle et al. Hemagglutination with the GDVII strain of mouse encephalomyelitis virus
US20090035837A1 (en) Virus Production
Hirst et al. A new method for concentrating influenza virus from allantoic fluid
Bang Filamentous forms of Newcastle virus
IE40180L (en) Influenza virus vaccines.
IE870507L (en) Bovine virus diarrhea and hog cholera vaccines
IE40221L (en) Influenza vaccines
Mims Rift Valley fever virus in mice. II. Adsorption and multiplication of virus
Manischewitz et al. The effect of mycoplasmas on replication and plaquing ability of Herpes simplex virus
GB1140316A (en) Influenza virus sub-unit vaccine
IE830861L (en) Equine influenza vaccine.
CA1270438A (en) Influenza vaccine
ES8107024A1 (es) Metodo para preparar una vacuna que contiene virus desacti- vado de peritonilis infecciosa felina.
JP2841592B2 (ja) ウイルス粒子の破砕法
GB1434181A (en) Vaccine for the prevention and treatment of vascular conditions
Greer et al. Electron microscope study of the interaction of vaccinia virus with macrophages from immunized and nonimmunized rabbits
GB777018A (en) Poliomyelitis vaccine products and methods for preparing the same
EP0374817A3 (en) Method for disrupting virus particles
WO2024186901A3 (en) Broadly reactive immunogens of influenza h3 virus, compositions and methods of use thereof
郭元吉 et al. Influenza C virus isolated from pigs in China
IE42043L (en) Influenza type b virus vaccines.
ES379053A3 (es) Procedimiento de preparacion de vacunas antiviricas.
IE33734L (en) Antigenic material